Navigation Links
Bayer's CONTOUR and Bayer's BREEZE2 Blood Glucose Monitoring Systems Do Not Use Problematic GDH-PQQ Technology
Date:8/14/2009

TARRYTOWN, N.Y., Aug. 14 /PRNewswire/ -- The U. S. Food and Drug Administration issued Advice for Diabetic Patients and their Caregivers on August 13, stating that blood glucose meters that use GDH-PQQ technology may "produce a falsely high (elevated) blood glucose result." Since 2006, Bayer Diabetes Care has not distributed test strips that use GDH-PQQ (glucose dehydrogenase pyrroloquinoline quinone) glucose monitoring technology for its blood glucose meters.

Bayer Diabetes Care is committed to patient safety and has a portfolio of blood glucose meters that all meet the current FDA requirements. The company adheres to and supports the highest standard of quality in its meters and strives to do everything possible by a manufacturer to ensure the accuracy of readings. Bayer Diabetes Care meters are designed to minimize the impact from as many external variants as possible, helping to ensure accuracy of readings. Bayer's BREEZE(R)2 and CONTOUR(R) systems both feature No Coding(TM) technology, and no interference with common substances including the non-glucose sugars maltose and galactose.

For more information on Bayer Diabetes Care blood glucose monitoring systems, visit www.bayerdiabetes.com.


'/>"/>
SOURCE Bayer Diabetes Care
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. National Ergonomics Expo Sees 86% On-Site Exhibitor Renewal Rate for 2009; New Products from Contour Design, Equipois, Goldtouch and Herman Miller Win 2008 NECE Attendees Choice New Product Awards
2. Contour Products Introduces Groundbreaking Sleep Apnea, Respiratory and Ergonomic Body Comfort Pillows at Medtrade; Self-Explanatory Products Serve Customer Needs, Expand Retailers DME Offerings
3. Fenwal and Golden Meditech Agree to Form Joint Venture in China for Blood Collection and Transfusion Technologies
4. Cord Blood America New Las Vegas Stem Cell Laboratory Scheduled for Opening in 4th Quarter 2009
5. Cord Blood America Retires $2.53M Obligation
6. Stem Cell Cord Blood Banking Is Huge Global Business for Hospitals, Says CEO of Bio-Matrix Scientific Group Inc.
7. Cellular Dynamics International Reprograms Blood Cells into Stem Cells
8. Cord Blood America Secured $7.5 Million Investment For Series A Preferred Stock
9. Exosome Diagnostics and DxS Diagnostic Innovations Collaborate to Develop Blood-Based Tests for Key Cancer Mutations
10. Cord Blood America Continues International Expansion
11. Study Finds Noninvasive Blood Test for Liver Fibrosis May Alleviate Need for Liver Biopsies for Some Patients with Chronic Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... , Feb. 22, 2017  PrimeVax Immuno-Oncology, Inc. announced ... presenting at the Annual Biocom Global Life Science Partnering ... at 11:15 AM, at the Torrey Pines Lodge, in ... the organizers at Biocom who have chosen our company, ... of biotechnology companies, investors, and clinical researchers," said Mr. ...
(Date:2/22/2017)... ... 22, 2017 , ... LabRoots , the leading provider of educational and ... pleased to announce the launch of a new scholarship for young scientists seeking a ... merit-based scholarship is open to all high school seniors, 17 years or older; as ...
(Date:2/22/2017)... ... February 22, 2017 , ... Pharma and biotech consulting firm ... director. Operating from Pennside’s Zurich headquarters, Pennside Partners, GmbH, Mr. Perkins brings 14 ... more than a decade with leading market research firm, GfK. He began his ...
(Date:2/21/2017)... ... February 21, 2017 , ... During HIMSS 2017, CloudMine, ... applications, announced a partnership with Redox, a leader in cloud-based healthcare integration and ... systems while keeping data secure in the cloud. , The digital health developers, ...
Breaking Biology Technology:
(Date:2/3/2017)...  Texas Biomedical Research Institute announced that its Board of ... as the Institute,s new President and CEO. Dr. Schlesinger will ... He is currently the Chair of the Department of Microbial ... Interface Biology at Ohio State University. "We are ... CEO of Texas Biomed," said Dr. James O. Rubin ...
(Date:2/2/2017)... 2017   TapImmune, Inc. (NASDAQ: ... in the development of innovative peptide and gene-based ... and metastatic disease, announced today it has successfully ... a second clinical lot of TPIV 200, the ... The manufactured vaccine product will be used to ...
(Date:2/2/2017)... 1, 2017  Central to its deep commitment ... worldwide, The Japan Prize Foundation today announced the ... pushed the envelope in their respective fields of ... scientists are being recognized with the 2017 Japan ... only contribute to the advancement of science and ...
Breaking Biology News(10 mins):